Insights

Decentralized clinical trials (DCTs) have evolved from a future concept to a present-day necessity. As protocols become more complex, competition for funding increases, and recruitment challenges persist, traditional site-centric models often fail to keep pace.

While clinical research professionals typically understand what has to be submitted to an Institutional Review Board (IRB), the board’s decision-making processes can seem like a ‘black box.’ A mock IRB meeting can be very illuminating, illustrating how regulatory mandates and ethical principles are reconciled with the realities of current clinical research.